MGNX (MGNX) Stock Price & Analysis
MGNX (MGNX) rose 3.53% to USD 4.4 as of September 8, 2026 at 05:45 UTC, according to Nexqual real-time market data.
MGNX last closed at USD 4.4; the session ranged USD 4.2–4.49 on volume of 442,785 shares. Market capitalization is —, with a 52-week range of USD 1.29–5.08 (NMS). Source: Nexqual, September 8, 2026 at 05:45 UTC.
Key Statistics (as of September 8, 2026 at 05:45 UTC)
| Price | USD 4.4 |
|---|---|
| Change | ▲ 3.53% (up) |
| Previous Close | USD 4.4 |
| Open | USD 4.4 |
| Day Range | USD 4.2 – 4.49 |
| 52-Week Range | USD 1.29 – 5.08 |
| Volume | 442,785 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MGNX)
Nexqual's technical model rates MGNX "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:45 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 55.5 (neutral) |
| vs SMA50 | Above (USD 4.2) |
| MACD | 0.04 (positive) |
From MGNX's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
| KYNB | Kyntra Bio, Inc. | USD 8.55 | ▲ 0.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:45 UTC. This page is informational and not investment advice.